BridgeBio Pharma, Inc. ( NASDAQ:BBIO – Get Rating ) CFO Brian C. Stephenson sold 55,500 shares of the business's stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total transaction of $857,475.00. Following the sale, the chief financial officer now directly owns 101,337 shares in the company, valued at approximately $1,565,656.65. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink .

https://www.dailypolitical.com/2023/04/07/brian-c-stephenson-sells-55500-shares-of-bridgebio-pharma-inc-nasdaqbbio-stock.html

#dailypolitical